Sarepta Therapeutics Statistics
Total Valuation
SRPT has a market cap or net worth of $1.79 billion. The enterprise value is $2.36 billion.
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SRPT has 97.71 million shares outstanding. The number of shares has decreased by -0.99% in one year.
| Current Share Class | 97.71M |
| Shares Outstanding | 97.71M |
| Shares Change (YoY) | -0.99% |
| Shares Change (QoQ) | +9.51% |
| Owned by Insiders (%) | 5.04% |
| Owned by Institutions (%) | 82.81% |
| Float | 87.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 13.26 |
| PS Ratio | 0.72 |
| Forward PS | 1.17 |
| PB Ratio | 1.32 |
| P/TBV Ratio | 1.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.95 |
| EV / EBITDA | 58.74 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.89, with a Debt / Equity ratio of 1.01.
| Current Ratio | 2.89 |
| Quick Ratio | 1.53 |
| Debt / Equity | 1.01 |
| Debt / EBITDA | 8.45 |
| Debt / FCF | n/a |
| Interest Coverage | -0.05 |
Financial Efficiency
Return on equity (ROE) is -4.76% and return on invested capital (ROIC) is -0.02%.
| Return on Equity (ROE) | -4.76% |
| Return on Assets (ROA) | -0.02% |
| Return on Invested Capital (ROIC) | -0.02% |
| Return on Capital Employed (ROCE) | -0.03% |
| Revenue Per Employee | $1.81M |
| Profits Per Employee | -$42,242 |
| Employee Count | 1,372 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 2.59 |
Taxes
In the past 12 months, SRPT has paid $33.83 million in taxes.
| Income Tax | 33.83M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.27% in the last 52 weeks. The beta is 0.49, so SRPT's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -85.27% |
| 50-Day Moving Average | 17.56 |
| 200-Day Moving Average | 60.17 |
| Relative Strength Index (RSI) | 50.90 |
| Average Volume (20 Days) | 6,719,012 |
Short Selling Information
The latest short interest is 20.28 million, so 20.75% of the outstanding shares have been sold short.
| Short Interest | 20.28M |
| Short Previous Month | 20.31M |
| Short % of Shares Out | 20.75% |
| Short % of Float | 23.13% |
| Short Ratio (days to cover) | 2.56 |
Income Statement
In the last 12 months, SRPT had revenue of $2.48 billion and -$57.96 million in losses. Loss per share was -$0.60.
| Revenue | 2.48B |
| Gross Profit | 565.14M |
| Operating Income | -932,000 |
| Pretax Income | -24.13M |
| Net Income | -57.96M |
| EBITDA | 40.15M |
| EBIT | -932,000 |
| Loss Per Share | -$0.60 |
Full Income StatementBalance Sheet
The company has $800.14 million in cash and $1.36 billion in debt, giving a net cash position of -$564.15 million or -$5.77 per share.
| Cash & Cash Equivalents | 800.14M |
| Total Debt | 1.36B |
| Net Cash | -564.15M |
| Net Cash Per Share | -$5.77 |
| Equity (Book Value) | 1.36B |
| Book Value Per Share | 13.89 |
| Working Capital | 1.74B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$300.75 million and capital expenditures -$150.79 million, giving a free cash flow of -$451.55 million.
| Operating Cash Flow | -300.75M |
| Capital Expenditures | -150.79M |
| Free Cash Flow | -451.55M |
| FCF Per Share | -$4.62 |
Full Cash Flow StatementMargins
Gross margin is 22.77%, with operating and profit margins of -0.04% and -2.34%.
| Gross Margin | 22.77% |
| Operating Margin | -0.04% |
| Pretax Margin | -0.97% |
| Profit Margin | -2.34% |
| EBITDA Margin | 1.62% |
| EBIT Margin | -0.04% |
| FCF Margin | n/a |
Dividends & Yields
SRPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.99% |
| Shareholder Yield | 0.99% |
| Earnings Yield | -3.23% |
| FCF Yield | -25.17% |
Dividend DetailsAnalyst Forecast
The average price target for SRPT is $40.61, which is 121.19% higher than the current price. The consensus rating is "Hold".
| Price Target | $40.61 |
| Price Target Difference | 121.19% |
| Analyst Consensus | Hold |
| Analyst Count | 31 |
| Revenue Growth Forecast (5Y) | -5.14% |
| EPS Growth Forecast (5Y) | 6.21% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 12, 2012. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jul 12, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
SRPT has an Altman Z-Score of 2.08 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.08 |
| Piotroski F-Score | 1 |